BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35619074)

  • 1. Factors associated with physician-reported treatment status of patients with osteoarthritis pain.
    Schnitzer TJ; Robinson RL; Tive L; Cappelleri JC; Bushmakin AG; Jackson J; Berry M; Barlow S; Walker C; Viktrup L
    BMC Musculoskelet Disord; 2022 May; 23(1):498. PubMed ID: 35619074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Satisfaction with Medications Prescribed for Osteoarthritis: A Cross-Sectional Survey of Patients and Their Physicians in the United States.
    Robinson RL; Schnitzer TJ; Barlow S; Berry M; Bushmakin AG; Cappelleri JC; Tive L; Jackson J; Jackson J; Viktrup L
    Pain Ther; 2022 Mar; 11(1):191-208. PubMed ID: 35028917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimodal Treatment Patterns for Osteoarthritis and Their Relationship to Patient-Reported Pain Severity: A Cross-Sectional Survey in the United States.
    Nalamachu SR; Robinson RL; Viktrup L; Cappelleri JC; Bushmakin AG; Tive L; Mellor J; Hatchell N; Jackson J
    J Pain Res; 2020; 13():3415-3425. PubMed ID: 33380823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Pain Severity and Opioid Use on Health Care Resource Utilization and Costs Among Patients with Knee and Hip Osteoarthritis.
    Wei W; Gandhi K; Blauer-Peterson C; Johnson J
    J Manag Care Spec Pharm; 2019 Sep; 25(9):957-965. PubMed ID: 31456495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlates of pain intensity in men and women with hip and knee osteoarthritis. Results of a national survey: The French ARTHRIX study.
    Perrot S; Poiraudeau S; Kabir-Ahmadi M; Rannou F
    Clin J Pain; 2009; 25(9):767-72. PubMed ID: 19851156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Which disease-related factors influence patients' and physicians' willingness to consider joint replacement in hip and knee OA? Results of a questionnaire survey linked to claims data.
    Postler A; Goronzy J; Günther KP; Lange T; Redeker I; Schmitt J; Zink A; Callhoff J
    BMC Musculoskelet Disord; 2020 Jun; 21(1):352. PubMed ID: 32503503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognosis of limitations in activities in osteoarthritis of the hip or knee: a 3-year cohort study.
    van Dijk GM; Veenhof C; Spreeuwenberg P; Coene N; Burger BJ; van Schaardenburg D; van den Ende CH; Lankhorst GJ; Dekker J;
    Arch Phys Med Rehabil; 2010 Jan; 91(1):58-66. PubMed ID: 20103397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medication and supplement use for managing joint symptoms among patients with knee and hip osteoarthritis: a cross-sectional study.
    Driban JB; Boehret SA; Balasubramanian E; Cattano NM; Glutting J; Sitler MR
    BMC Musculoskelet Disord; 2012 Mar; 13():47. PubMed ID: 22458305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence of foot pain and association with baseline characteristics in people participating in education and supervised exercise for knee or hip osteoarthritis: a cross-sectional study of 26,003 participants from the GLA:D® registry.
    Gates LS; Cherry L; Grønne DT; Roos EM; Skou ST
    J Foot Ankle Res; 2023 Nov; 16(1):83. PubMed ID: 37993923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee.
    Hochberg MC; Altman RD; April KT; Benkhalti M; Guyatt G; McGowan J; Towheed T; Welch V; Wells G; Tugwell P;
    Arthritis Care Res (Hoboken); 2012 Apr; 64(4):465-74. PubMed ID: 22563589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes and Factors Influencing Response to an Individualized Multidisciplinary Chronic Disease Management Program for Hip and Knee Osteoarthritis.
    Gwynne-Jones DP; Gray AR; Hutton LR; Stout KM; Abbott JH
    J Arthroplasty; 2018 Sep; 33(9):2780-2786. PubMed ID: 29739632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Younger age is associated with greater pain expression among patients with knee or hip osteoarthritis scheduled for a joint arthroplasty.
    Skogö Nyvang J; Naili JE; Iversen MD; Broström EW; Hedström M
    BMC Musculoskelet Disord; 2019 Aug; 20(1):365. PubMed ID: 31391043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors Associated With the Outcome of a First-Line Intervention for Patients With Hip or Knee Osteoarthritis or Both: Data From the BOA Register.
    Dell'Isola A; Jönsson T; Nero H; Eek F; Dahlberg L
    Phys Ther; 2020 Sep; 100(10):1771-1781. PubMed ID: 32589713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of neuromuscular training (NEMEX-TJR) on patient-reported outcomes and physical function in severe primary hip or knee osteoarthritis: a controlled before-and-after study.
    Ageberg E; Nilsdotter A; Kosek E; Roos EM
    BMC Musculoskelet Disord; 2013 Aug; 14():232. PubMed ID: 23924144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analgesic use in patients with knee and/or hip osteoarthritis referred to an outpatient center: a cross-sectional study within the Amsterdam Osteoarthritis Cohort.
    Knoop J; van Tunen J; van der Esch M; Roorda LD; Dekker J; van der Leeden M; Lems WF
    Rheumatol Int; 2017 Oct; 37(10):1747-1755. PubMed ID: 28821939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medication taking in people with hip and knee osteoarthritis: An analysis of the English Longitudinal Study of Ageing.
    Smith TO; Kemp A; Twigg MJ
    Musculoskeletal Care; 2018 Dec; 16(4):450-457. PubMed ID: 30160828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a Massive Open Online Course on osteoarthritis knowledge and pain self-efficacy in people with hip and/or knee osteoarthritis: protocol for the MOOC-OA randomised controlled trial.
    Nelligan RK; Hinman RS; Egerton T; Gregory M; Bidgood N; McManus MF; De Silva AP; Lamb KE; Bennell KL
    BMC Musculoskelet Disord; 2023 May; 24(1):381. PubMed ID: 37189094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of low-dose transdermal buprenorphine patches (5, 10, and 20 microg/h) versus prolonged-release tramadol tablets (75, 100, 150, and 200 mg) in patients with chronic osteoarthritis pain: a 12-week, randomized, open-label, controlled, parallel-group noninferiority study.
    Karlsson M; Berggren AC
    Clin Ther; 2009 Mar; 31(3):503-13. PubMed ID: 19393841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of adding aerobic physical activity to strengthening exercise on hip osteoarthritis symptoms: protocol for the PHOENIX randomised controlled trial.
    Hall M; Allison K; Hinman RS; Bennell KL; Spiers L; Knox G; Plinsinga M; Klyne DM; McManus F; Lamb KE; Da Costa R; Murphy NJ; Dobson FL
    BMC Musculoskelet Disord; 2022 Apr; 23(1):361. PubMed ID: 35436914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body mass and osteoarthritic pain: results from a study in general practice.
    Cimmino MA; Scarpa R; Caporali R; Parazzini F; Zaninelli A; Sarzi-Puttini P
    Clin Exp Rheumatol; 2013; 31(6):843-9. PubMed ID: 24144227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.